Touchwood Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio

MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio GlobeNewswire January 10, 2022 MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed Contacts:Media: Will Harris, VP Marketing, MeMedpr@me-med.com IR: Kfir Emmer, CFO, MeMedkfir.emmer@me-med.comMedia Contacts:Consilium Strategic CommunicationsMeMed@consilium-comms.com

United statesPatrick zhangKfir emmerUs department of defenseCaesara medical holdingsTechnology investmentEu commissionDrug administrationUnion tech venturesConsilium strategic communicationsMemed keyHorizons venturesShavit capitalSocial capitalTouchwood capitalClai insurance

MeMed raises $93 million to translate the immune system

The Israeli company recently received FDA approval for its MeMed BV test to help healthcare providers distinguish between bacterial and viral infections

United statesMemed covidUs department of defenseTechnology investmentCaesarea medical holdingsEu commissionDrug administrationUnion tech venturesHorizons venturesShavit capitalSocial capitalTouchwood capitalClai insurancePhoenix insurancePoalim equityWestern technology

MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio

MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed BV test recently cleared for use by US FDA to aid in distinguishing between bacterial and

United statesKostenloser wertpapierhandelPatrick zhangKfir emmerUs department of defenseCaesara medical holdingsTechnology investmentEu commissionDrug administrationUnion tech venturesConsilium strategic communicationsMemed keyHorizons venturesShavit capitalSocial capitalTouchwood capital

MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesPatrick zhangKfir emmerUs department of defenseCaesara medical holdingsTechnology investmentEu commissionDrug administrationUnion tech venturesConsilium strategic communicationsMemed keyHorizons venturesShavit capitalSocial capitalTouchwood capitalClai insurance

MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio

MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio
newsmakers.pk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsmakers.pk Daily Mail and Mail on Sunday newspapers.

United statesPatrick zhangKfir emmerUs department of defenseCaesara medical holdingsTechnology investmentEu commissionDrug administrationUnion tech venturesMemed keyHorizons venturesShavit capitalSocial capitalTouchwood capitalClai insurancePhoenix insurance